Copyright © 2010 Katarzyna A. Piróg and Michael D. Briggs. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. C. A. Francomano, I. McIntosh, and D. J. Wilkin, “Bone dysplasias in man: molecular insights,” Current Opinion in Genetics and Development, vol. 6, no. 3, pp. 301–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
2. P. J. Mogayzel and C. L. Marcus, “Skeletal dysplasias and their effect on the respiratory system,” Paediatric Respiratory Reviews, vol. 2, no. 4, pp. 365–371, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. S.-I. Harada and G. A. Rodan, “Control of osteoblast function and regulation of bone mass,” Nature, vol. 423, no. 6937, pp. 349–355, 2003. View at Publisher · View at Google Scholar · View at PubMed
4. H. M. Frost, “Biomechanical control of knee alignment: some insights from a new paradigm,” Clinical Orthopaedics and Related Research, no. 335, pp. 335–342, 1997.
5. P. M. Royce and B. Heinmann, Connective Tissue and Its Heritable Disorders, John Wiley & Sons, Zurich, Switzerland, 2nd edition, 2002.
6. Encyclopedia Britannica.
7. G. Karsenty, “The complexities of skeletal biology,” Nature, vol. 423, no. 6937, pp. 316–318, 2003. View at Publisher · View at Google Scholar · View at PubMed
8. B. R. Olsen, A. M. Reginato, and W. Wang, “Bone development,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 191–220, 2000. View at Publisher · View at Google Scholar · View at PubMed
9. E. Zelzer and B. R. Olsen, “Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair,” Current Topics in Developmental Biology, vol. 65, pp. 169–187, 2004. View at Publisher · View at Google Scholar · View at PubMed
10. H. M. Kronenberg, “Developmental regulation of the growth plate,” Nature, vol. 423, no. 6937, pp. 332–336, 2003. View at Publisher · View at Google Scholar · View at PubMed
11. F. Forriol and F. Shapiro, “Bone development: interaction of molecular components and biophysical forces,” Clinical Orthopaedics and Related Research, no. 432, pp. 14–33, 2005. View at Publisher · View at Google Scholar
12. A. Guadalupe-Grau, T. Fuentes, B. Guerra, and J. A. L. Calbet, “Exercise and bone mass in adults,” Sports Medicine, vol. 39, no. 6, pp. 439–468, 2009. View at Publisher · View at Google Scholar
13. W. A. Horton, “Skeletal development: insights from targeting the mouse genome,” The Lancet, vol. 362, no. 9383, pp. 560–569, 2003. View at Publisher · View at Google Scholar · View at PubMed
14. J. A. Ogden and L. C. Rosenberg, “Defining the growth plate,” in Behaviour of the Growth Plate, H. K. Uhthoff and J. J. Wiley, Eds., Raven Press, New York, NY, USA, 1988.
15. N. Ortega, D. J. Behonick, and Z. Werb, “Matrix remodeling during endochondral ossification,” Trends in Cell Biology, vol. 14, no. 2, pp. 86–93, 2004. View at Publisher · View at Google Scholar · View at PubMed
16. S. F. Gilbert, Developmental Biology, Sinauer Associates, Sunderland, Mass, USA, 6th edition, 2000.
17. F. Rauch, “Bone growth in length and width: the Yin and Yang of bone stability,” Journal of Musculoskeletal Neuronal Interactions, vol. 5, no. 3, pp. 194–201, 2005.
18. P. H. L. de Freitas, T. Kojima, S. Ubaidus, et al., “Histological assessments on the abnormalities of mouse epiphyseal chondrocytes with short term centrifugal loading,” Biomedical Research, vol. 28, no. 4, pp. 191–203, 2007. View at Publisher · View at Google Scholar
19. A. C. Abram, T. S. Keller, and D. M. Spengler, “The effects of simulated weightlessness on bone biomechanical and biochemical properties in the maturing rat,” Journal of Biomechanics, vol. 21, no. 9, pp. 755–767, 1988.
20. T. J. Wronski and E. R. Morey, “Recovery of the rat skeleton from the adverse effects of simulated weightlessness,” Metabolic Bone Disease and Related Research, vol. 4, no. 6, pp. 347–352, 1983.
21. M. M. Shimano and J. B. Volpon, “Biomechanics and structural adaptations of the rat femur after hindlimb suspension and treadmill running,” Brazilian Journal of Medical and Biological Research, vol. 42, no. 4, pp. 330–338, 2009.
22. S. R. McGlashan, C. G. Jensen, and C. A. Poole, “Localization of extracellular matrix receptors on the chondrocyte primary cilium,” Journal of Histochemistry & Cytochemistry, vol. 54, no. 9, pp. 1005–1014, 2006. View at Publisher · View at Google Scholar · View at PubMed
23. J. F. Whitfield, “The solitary (primary) cilium-A mechanosensory toggle switch in bone and cartilage cells,” Cellular Signalling, vol. 20, no. 6, pp. 1019–1024, 2008. View at Publisher · View at Google Scholar · View at PubMed
24. N. F. Berbari, A. K. O'Connor, C. J. Haycraft, and B. K. Yoder, “The primary cilium as a complex signaling center,” Current Biology, vol. 19, no. 13, pp. R526–R535, 2009. View at Publisher · View at Google Scholar · View at PubMed
25. W. A. Beresford, Lecture Notes on Histology, Blackwell Scientific, Oxford, UK, 3rd edition, 1983.
26. C. A. Poole, A. Matsuoka, and J. R. Schofield, “Chondrons from articular cartilage: III. Morphologic changes in the cellular microenvironment of chondrons isolated from osteoarthritic cartilage,” Arthritis and Rheumatism, vol. 34, no. 1, pp. 22–35, 1991. View at Publisher · View at Google Scholar
27. C. A. Poole, “Articular cartilage chondrons: form, function and failure,” Journal of Anatomy, vol. 191, no. 1, pp. 1–13, 1997. View at Publisher · View at Google Scholar
28. L. Stryer, Biochemistry, W.H. Freeman, New York, NY, USA, 4th edition, 2000.
29. F. Guilak, A. Ratcliffe, and V. C. Mow, “Chondrocyte deformation and local tissue strain in articular cartilage: a confocal microscopy study,” Journal of Orthopaedic Research, vol. 13, no. 3, pp. 410–421, 1995. View at Publisher · View at Google Scholar · View at PubMed
30. K. L. Bennell, M. A. Hunt, T. V. Wrigley, B.-W. Lim, and R. S. Hinman, “Role of muscle in the genesis and management of knee osteoarthritis,” Rheumatic Disease Clinics of North America, vol. 34, no. 3, pp. 731–754, 2008. View at Publisher · View at Google Scholar · View at PubMed
31. K. D. Brandt, “Putting some muscle into osteoarthritis,” Annals of Internal Medicine, vol. 127, no. 2, pp. 154–156, 1997.
32. M. Benjamin, H. Toumi, J. R. Ralphs, G. Bydder, T. M. Best, and S. Milz, “Where tendons and ligaments meet bone: attachment sites (‘entheses’) in relation to exercise and/or mechanical load,” Journal of Anatomy, vol. 208, no. 4, pp. 471–490, 2006. View at Publisher · View at Google Scholar · View at PubMed
33. G. Riley, “Tendinopathy—from basic science to treatment,” Nature Clinical Practice Rheumatology, vol. 4, no. 2, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at PubMed
34. M. Benjamin and J. R. Ralphs, “Tendons in health and disease,” Manual Therapy, vol. 1, no. 4, pp. 186–191, 1996. View at Publisher · View at Google Scholar · View at PubMed
35. M. Benjamin and E. J. Evans, “Fibrocartilage,” Journal of Anatomy, vol. 171, pp. 1–15, 1990.
36. S. L.-Y. Woo, J. A. Weiss, and D. A. M. Da, “Biomechanics and morphology of the medial collateral and anterior cruciate ligaments,” in Biomechanics of Diarthrodial Joints, V. C. Mow and S. L.-Y. Woo, Eds., Springer, New York, NY, USA, 1990.
37. O. S. Mian, J. M. Thom, L. P. Ardigò, A. E. Minetti, and M. V. Narici, “Gastrocnemius muscle-tendon behaviour during walking in young and older adults,” Acta Physiologica, vol. 189, no. 1, pp. 57–65, 2007. View at Publisher · View at Google Scholar · View at PubMed
38. M. Kjær, “Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading,” Physiological Reviews, vol. 84, no. 2, pp. 649–698, 2004. View at Publisher · View at Google Scholar · View at PubMed
39. J. Savolainen, K. Vaananen, J. Puranen, T. E. S. Takala, J. Komulainen, and V. Vihko, “Collagen synthesis and proteolytic activities in rat skeletal muscles: effect of cast-immobilization in the lengthened and shortened positions,” Archives of Physical Medicine and Rehabilitation, vol. 69, no. 11, pp. 964–969, 1988.
40. A. Arampatzis, K. Karamanidis, and K. Albracht, “Adaptational responses of the human Achilles tendon by modulation of the applied cyclic strain magnitude,” The Journal of Experimental Biology, vol. 210, no. 15, pp. 2743–2753, 2007. View at Publisher · View at Google Scholar · View at PubMed
41. M. V. Narici, C. N. Maganaris, and N. D. Reeves, “Myotendinous alterations and effects of resistive loading in old age,” Scandinavian Journal of Medicine and Science in Sports, vol. 15, no. 6, pp. 392–401, 2005. View at Publisher · View at Google Scholar · View at PubMed
42. J. G. Tidball and T. L. Daniel, “Myotendinous junctions of tonic muscle cells: structure and loading,” Cell and Tissue Research, vol. 245, no. 2, pp. 315–322, 1986.
43. E. Passerieux, R. Rossignol, T. Letellier, and J. P. Delage, “Physical continuity of the perimysium from myofibers to tendons: involvement in lateral force transmission in skeletal muscle,” Journal of Structural Biology, vol. 159, no. 1, pp. 19–28, 2007. View at Publisher · View at Google Scholar · View at PubMed
44. P. A. Huijing, “Muscle as a collagen fiber reinforced composite: a review of force transmission in muscle and whole limb,” Journal of Biomechanics, vol. 32, no. 4, pp. 329–345, 1999. View at Publisher · View at Google Scholar
45. J. V. Pardo, J. D'Angelo Siliciano, and S. W. Craig, “A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements (“costameres”) mark sites of attachment between myofibrils and sarcolemma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 4, pp. 1008–1012, 1983.
46. S. F. Street, “Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters,” Journal of Cellular Physiology, vol. 114, no. 3, pp. 346–364, 1983.
47. S. R. Garfin, C. M. Tipton, S. J. Mubarak, et al., “Role of fascia in maintenance of muscle tension and pressure,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 51, no. 2, pp. 317–320, 1981.
48. J. G. Tidball, “Force transmission across muscle cell membranes,” Journal of Biomechanics, vol. 24, supplement 1, pp. 43–52, 1991. View at Publisher · View at Google Scholar
49. A. L. Mackey, K. M. Heinemeier, S. O. A. Koskinen, and M. Kjaer, “Dynamic adaptation of tendon and muscle connective tissue to mechanical loading,” Connective Tissue Research, vol. 49, no. 3-4, pp. 165–168, 2008. View at Publisher · View at Google Scholar · View at PubMed
50. S. M. Phillips, “Physiologic and molecular bases of muscle hypertrophy and atrophy: impact of resistance exercise on human skeletal muscle (protein and exercise dose effects),” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 403–410, 2009. View at Publisher · View at Google Scholar · View at PubMed
51. D. L. Rimoin, G. A. Francomano, A. Giedion, et al., “International nomenclature and classification of the osteochondrodysplasias (1997) international working group on constitutional diseases of bone,” American Journal of Medical Genetics, vol. 79, no. 5, pp. 376–382, 1998.
52. G. R. Mortier, “The diagnosis of skeletal dysplasias: a multidisciplinary approach,” European Journal of Radiology, vol. 40, no. 3, pp. 161–167, 2001. View at Publisher · View at Google Scholar
53. E. Jakkula, J. Lohiniva, A. Capone, et al., “A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations,” Journal of Medical Genetics, vol. 40, no. 12, pp. 942–948, 2003.
54. C. G. Bönnemann, G. F. Cox, F. Shapiro, et al., “A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 3, pp. 1212–1217, 2000. View at Publisher · View at Google Scholar
55. J. Kennedy, G. C. Jackson, F. S. Barker, et al., “Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia—multiple epiphyseal dysplasia disease group,” Human Mutation, vol. 25, no. 6, pp. 593–594, 2005.
56. J. Spranger, “Pattern recognition in bone dysplasias,” Progress in Clinical and Biological Research, vol. 200, pp. 315–342, 1985.
57. A. Mabuchi, N. Manabe, N. Haga, et al., “Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia,” Human Genetics, vol. 112, no. 1, pp. 84–90, 2003. View at Publisher · View at Google Scholar · View at PubMed
58. J. McKeand, J. Rotta, and J. T. Hecht, “Natural history study of pseudoachondroplasia,” American Journal of Medical Genetics, vol. 63, no. 2, pp. 406–410, 1996. View at Publisher · View at Google Scholar
59. M. D. Briggs, S. M. G. Huffman, L. M. King, et al., “Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene,” Nature Genetics, vol. 10, no. 3, pp. 330–336, 1995. View at Publisher · View at Google Scholar · View at PubMed
60. K. L. Chapman, M. D. Briggs, and G. R. Mortier, “Review: clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia,” Pediatric Pathology and Molecular Medicine, vol. 22, no. 1, pp. 53–75, 2003. View at Publisher · View at Google Scholar
61. K. Halász, A. Kassner, M. Mörgelin, and D. Heinegård, “COMP acts as a catalyst in collagen fibrillogenesis,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31166–31173, 2007. View at Publisher · View at Google Scholar · View at PubMed
62. P. E. Di Cesare, F. S. Chen, M. Moergelin, et al., “Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin,” Matrix Biology, vol. 21, no. 5, pp. 461–470, 2002. View at Publisher · View at Google Scholar
63. H. H. Mann, S. Özbek, J. Engel, M. Paulsson, and R. Wagener, “Interactions between the cartilage oligomeric matrix protein and matrilins: implications for matrix assembly and the pathogenesis of chondrodysplasias,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 25294–25298, 2004. View at Publisher · View at Google Scholar · View at PubMed
64. P. Holden, R. S. Meadows, K. L. Chapman, M. E. Grant, K. E. Kadler, and M. D. Briggs, “Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 6046–6055, 2001. View at Publisher · View at Google Scholar · View at PubMed
65. M. J. Rock, P. Holden, W. A. Horton, and D. H. Cohn, “Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and $\alpha$V$\beta$3 integrin,” Molecular and Cellular Biochemistry, vol. 338, no. 1-2, pp. 215–224, 2010. View at Publisher · View at Google Scholar · View at PubMed
66. W. Müller-Glauser, B. Humbel, M. Glatt, et al., “On the role of type IX collagen in the extracellular matrix of cartilage: type IX collagen is localized to intersections of collagen fibrils,” Journal of Cell Biology, vol. 102, no. 5, pp. 1931–1939, 1986.
67. M. H. Irwin, S. H. Silvers, and R. Mayne, “Monoclonal antibody against chicken type IX collagen: preparation, characterization, and recognition of the intact form of type IX collagen secreted by chondrocytes,” Journal of Cell Biology, vol. 101, no. 3, pp. 814–823, 1985.
68. G. C. Jackson, D. Marcus-Soekarman, I. Stolte-Dijkstra, A. Verrips, J. A. Taylor, and M. D. Briggs, “Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy,” American Journal of Medical Genetics, Part A, vol. 152, no. 4, pp. 863–869, 2010. View at Publisher · View at Google Scholar · View at PubMed
69. C. Fang, C. S. Carlson, M. P. Leslie, et al., “Molecular cloning, sequencing, and tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP),” Journal of Orthopaedic Research, vol. 18, no. 4, pp. 593–603, 2000.
70. L. Svensson, A. Aszódi, D. Heinegård, et al., “Cartilage oligomeric matrix protein-deficient mice have normal skeletal development,” Molecular and Cellular Biology, vol. 22, no. 12, pp. 4366–4371, 2002. View at Publisher · View at Google Scholar
71. K. A. Piróg, O. Jaka, Y. Katakura, et al., “A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia,” Human Molecular Genetics, vol. 19, no. 1, pp. 52–64, 2009. View at Publisher · View at Google Scholar · View at PubMed
72. K. Tan, M. Duquette, A. Joachimiak, and J. Lawler, “The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding,” FASEB Journal, vol. 23, no. 8, pp. 2490–2501, 2009. View at Publisher · View at Google Scholar · View at PubMed
73. C. B. Carlson, D. A. Bernstein, D. S. Annis, et al., “Structure of the calcium-rich signature domain of human thrombospondin-2,” Nature Structural and Molecular Biology, vol. 12, no. 10, pp. 910–914, 2005. View at Publisher · View at Google Scholar · View at PubMed
74. F. Deák, R. Wagener, I. Kiss, and M. Paulsson, “The matrilins: a novel family of oligomeric extracellular matrix proteins,” Matrix Biology, vol. 18, no. 1, pp. 55–64, 1999. View at Publisher · View at Google Scholar
75. O. Schwartz and R. S. Jampel, “Congenital blepharophimosis associated with a unique generalized myopathy,” Archives of Ophthalmology, vol. 68, pp. 52–57, 1962.
76. S. Nicole, C.-S. Davoine, H. Topaloglu, et al., “Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia),” Nature Genetics, vol. 26, no. 4, pp. 480–483, 2000. View at Publisher · View at Google Scholar · View at PubMed
77. R. V. Iozzo, J. Pillarisetti, B. Sharma, et al., “Structural and functional characterization of the human perlecan gene promoter: transcriptional activation by transforming growth factor-$\beta$ via a nuclear factor 1-binding element,” Journal of Biological Chemistry, vol. 272, no. 8, pp. 5219–5228, 1997. View at Publisher · View at Google Scholar
78. A. C. van Huffelen, F. J. M. Gabreels, J. S. van Luypen van der Horst, et al., “Chondrodystrophic myotonia. A report of two unrelated Dutch patients,” Neuropadiatrie, vol. 5, no. 1, pp. 71–90, 1974.
79. P. R. Huttenlocher, J. Landwirth, V. Hanson, B. B. Gallagher, and K. Bensch, “Osteo-chondro-muscular dystrophy. A disorder manifested by multiple skeletal deformities, myotonia, and dystrophic changes in muscle,” Pediatrics, vol. 44, no. 6, pp. 945–958, 1969.
80. L. Y. Sakai, D. R. Keene, and E. Engvall, “Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils,” Journal of Cell Biology, vol. 103, no. 6, pp. 2499–2509, 1986.
81. J. R. Gray and S. J. Davies, “Marfan syndrom,” Journal of Medical Genetics, vol. 33, no. 5, pp. 403–408, 1996.
82. W. M. H. Behan, C. Longman, R. K. H. Petty, et al., “Muscle fibrillin deficiency in Marfan's syndrome myopathy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 5, pp. 633–638, 2003. View at Publisher · View at Google Scholar
83. N. C. Voermans, C. G. Bönnemann, P. A. Huijing, et al., “Clinical and molecular overlap between myopathies and inherited connective tissue diseases,” Neuromuscular Disorders, vol. 18, no. 11, pp. 843–856, 2008. View at Publisher · View at Google Scholar · View at PubMed
84. J. P. Habashi, D. P. Judge, T. M. Holm, et al., “Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome,” Science, vol. 312, no. 5770, pp. 117–121, 2006. View at Publisher · View at Google Scholar · View at PubMed
85. A. Campos-Xavier, J. M. Saraiva, R. Savarirayan, et al., “Phenotypic variability at the TGF-$\beta$1 locus in Camurati-Engelmann disease,” Human Genetics, vol. 109, no. 6, pp. 653–658, 2001. View at Publisher · View at Google Scholar · View at PubMed
86. M. Ghadami, Y. Makita, K. Yoshida, et al., “Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3,” American Journal of Human Genetics, vol. 66, no. 1, pp. 143–147, 2000. View at Publisher · View at Google Scholar
87. M. E. Dickinson, M. S. Kobrin, C. M. Silan, et al., “Chromosomal localization of seven members of th murine TGF-$\beta$ superfamily suggests close linkage to several morphogenetic mutant loci,” Genomics, vol. 6, no. 3, pp. 505–520, 1990. View at Publisher · View at Google Scholar
88. J. Bondestam, H. Pihko, S.-L. Vanhanen, et al., “Skeletal dysplasia presenting as a neuromuscular disorder—report of three children,” Neuromuscular Disorders, vol. 17, no. 3, pp. 231–234, 2007. View at Publisher · View at Google Scholar · View at PubMed
89. H. Yoshioka, M. Mino, N. Kiyosawa, et al., “Muscular changes in Engelmann's disease,” Archives of Disease in Childhood, vol. 55, no. 9, pp. 716–719, 1980.
90. T. Inaoka, N. Shuke, J. Sato, et al., “Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease),” Clinical Nuclear Medicine, vol. 26, no. 8, pp. 680–682, 2001. View at Publisher · View at Google Scholar